We had our exciting BETTER-B Final Conferences on the 4th and 11th of December 2023. These online events were dedicated to exploring the management of refractory breathlessness. BETTER-B stands for BETtter TrEatments for Refractory Breathlessness and aims to improve the care of patients suffering from severe breathlessness caused by long-term lung conditions. The BETTER-B programme started in 2019 and is now coming to an end on the 31st of December 2023.
On the 4th of December 2023, speakers included Professor Matthew Maddocks who provided an overview of the BETTER-B programme. Professor Bobbie Farsides, the chair of the Ethics Advisory Board, spoke about the ethical aspects of BETTER-B while Dr Sabrina Bajwah touched on the use of benzodiazepines in breathlessness management. Dr Claire Nolan further presented the evidence on meditative movement for breathlessness in advanced Chronic Obstructive Pulmonary Disease (COPD) or cancer.
On the 11th of December 2023, Professor Irene Higginson (BETTER-B chief investigator) presented on the importance of the BETTER-B programme. Furthermore, Professor Malgorzata Krajnik led the BETTER-B survey and presented its results, showing wide variations in how breathlessness is managed. Dr Adejoke Oluyase spoke on the BETTER-B trial processes and delivery, highlighting that this is now the largest trial of mirtazapine for breathlessness globally.
The conferences brought together experts in breathlessness management, researchers, people affected by breathlessness, charities and policy makers. The conferences were well received with a total of 210 people in attendance.
To download the presentation slides from both days, click here.